The launch of American cannabis companies into the European market is a major development in the global cannabis industry. Of course there are difficulties to be overcome. These can be navigating the complicated regulatory environment and competing with well-established European businesses. However, there are also huge possibilities for American businesses to increase their revenue. Thus, there are several examples of American cannabis companies that have launched in Europe or announced plans to do so.
Cannabis business Curaleaf, headquartered in Massachusetts, has operations in several US states. The business declared intentions to enter Europe in 2020, concentrating on the UK and Germany. Since then, Curaleaf has bought a medicinal marijuana distributor in Germany and set up a joint venture in the UK.
Currently employing over 6,000 team members and operating in 21 states across the United States, Curaleaf has 137 dispensaries and 26 growing facilities. The biggest vertically integrated cannabis business in Europe, Curaleaf International has a specialized supply and distribution network covering the entire European market. It combines cutting-edge science and research with cutting-edge cultivation, extraction, and production. The Canadian Stock Exchange lists Curaleaf. Curaleaf Holdings entered the European cannabis market with the acquisition of EMMAC Life Sciences Limited in 2021.
Aurora has a patient-first ethos because it is a medical business at heart and a market leader in medical cannabis. Not from the US, but as a division of Aurora Cannabis Inc. (Alberta, Canada), Aurora Europe is a world leader in the cannabis business serving both the medical and recreational markets and committed to enhancing people’s lives. Aurora Europe is based in Berlin, Germany. Patients in all of Europe can purchase high-quality medical cannabis products made with pharmaceutical grade cannabis from the business. Aurora entered the German market in 2017. It is currently one of Europe’s biggest licensed importers and distributors of medical cannabis.
Ambari Brands is happy to reveal that it has increased the reach of its European distribution, moving beyond online sales in nearly all of the continent’s nations to include El Corte Ingles, the continent’s biggest retailer. They will initially continue its growth into the Nordic countries before moving into Germany, France, and Portugal. In preparation of the legalization of cannabis in Germany in 2023, Ambari Brands intends to concentrate on opening brick-and-mortar stores there. Currently, Ambari Brands is one of America’s top producers of CBD and cannabis products. Nearly all of the big American publications have written about Ambari, which is steadily expanding. It presently produces CBD skin care products and plans to broaden its product line to include vapes, gummies, and capsules as well as indoor cannabis grow rooms and outdoor hemp production for CBD extraction.
Launch of American cannabis companies into European market – predictions
These are just a few examples of American cannabis businesses that have already sold their products in Europe or have made preparations to do so. More American businesses will probably follow example as the European cannabis market develops and grows. However, it is important to keep in mind that cannabis regulation in Europe is complicated and differs from nation to nation. Although most European nations consider CBD products to be lawful in general, some products cannot be sold or marketed. To ensure compliance and prevent legal problems, businesses joining the European market must carefully navigate these regulations.